{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:29:49Z","timestamp":1793147389659,"version":"4.5.0"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K01 MH117343"],"award-info":[{"award-number":["K01 MH117343"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS089515"],"award-info":[{"award-number":["R01 NS089515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS065842"],"award-info":[{"award-number":["R01 NS065842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cytogfr.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T08:12:17Z","timestamp":1613895137000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders"],"prefix":"10.1016","volume":"58","author":[{"given":"Narayanappa","family":"Amruta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5360-4890","authenticated-orcid":false,"given":"Wesley H.","family":"Chastain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshi","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-9229","authenticated-orcid":false,"given":"Rebecca J.","family":"Solch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3077-5216","authenticated-orcid":false,"given":"Isabel C.","family":"Murray-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime B.","family":"Befeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Gressett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele T.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Engler-Chiurazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Bix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234765","article-title":"The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries","volume":"15","author":"Grant","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12519-020-00368-y","article-title":"SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China","volume":"16","author":"Sun","year":"2020","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fpubh.2020.00216","article-title":"COVID-19: emergence, spread, possible treatments, and global burden","volume":"8","author":"Keni","year":"2020","journal-title":"Front. Public Health"},{"issue":"19","key":"10.1016\/j.cytogfr.2021.02.002_bib0025","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.74.19.8913-8921.2000","article-title":"Neuroinvasion by human respiratory coronaviruses","volume":"74","author":"Arbour","year":"2000","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid1002.030638","article-title":"Possible central nervous system infection by SARS coronavirus","volume":"10","author":"Lau","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"17","key":"10.1016\/j.cytogfr.2021.02.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00404-18","article-title":"Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43","volume":"92","author":"Dub\u00e9","year":"2018","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"19","key":"10.1016\/j.cytogfr.2021.02.002_bib0050","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1128\/JVI.01501-15","article-title":"Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and Beta interferon production in brain microvascular endothelial cells","volume":"89","author":"Bleau","year":"2015","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.02.002_bib0055","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0060","article-title":"The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection","author":"Beddingfield","year":"2020","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0065","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1177\/0271678X19880161","article-title":"Integrin alpha5beta1 inhibition by ATN-161 reduces neuroinflammation and is neuroprotective in ischemic stroke","volume":"40","author":"Edwards","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152021","article-title":"SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19","volume":"226","author":"Dakal","year":"2020","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2020.04.124","article-title":"COVID-19, SARS and MERS: a neurological perspective","volume":"77","author":"Ng Kee Kwong","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18683\/germs.2019.1155","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): a review","volume":"9","author":"Ramadan","year":"2019","journal-title":"Germs"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12985-015-0439-5","article-title":"MERS coronavirus: diagnostics, epidemiology and transmission","volume":"12","author":"Mackay","year":"2015","journal-title":"Virol. J."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.02.002_bib0105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s13760-020-01412-4","article-title":"Neurological manifestations of COVID-19, SARS and MERS","volume":"120","author":"Verstrepen","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa021","article-title":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","volume":"27","author":"Liu","year":"2020","journal-title":"J. Travel Med."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101742","article-title":"Time series modelling to forecast the confirmed and recovered cases of COVID-19","volume":"37","author":"Maleki","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"172","author":"Lauer","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039652","article-title":"Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research","volume":"10","author":"McAloon","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0135","series-title":"COVID-19 and False Dichotomies\u2014A Nuanced Review of the Evidence Regarding Public Health, COVID-19 Symptomatology, SARS-CoV-2 Transmission, Masks, and Reinfection., Osf.Io","author":"Escand\u00f3n","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0140","series-title":"COVID-19 and False Dichotomies\u2014A Nuanced Review of the Evidence Regarding Public Health, COVID-19 Symptomatology, SARS-CoV-2 Transmission, Masks, and Reinfection","author":"Escand\u00f3n","year":"2020"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID-19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0155","article-title":"Genomic characterization of a novel SARS-CoV-2","volume":"19","author":"Khailany","year":"2020","journal-title":"Gene Rep."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-020-00126-7","article-title":"Genome evolution of SARS-CoV-2 and its virological characteristics","volume":"40","author":"Nakagawa","year":"2020","journal-title":"Inflamm. Regen"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.aivir.2016.08.004","article-title":"Coronavirus spike protein and tropism changes","volume":"96","author":"Hulswit","year":"2016","journal-title":"Adv. Virus Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0175","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s10096-020-03899-4","article-title":"The genetic sequence, origin, and diagnosis of SARS-CoV-2","volume":"39","author":"Wang","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.arcmed.2020.05.012","article-title":"Structural proteins in severe acute respiratory syndrome coronavirus-2","volume":"51","author":"Satarker","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173451","article-title":"COVID-19: a review of the proposed pharmacological treatments","volume":"886","author":"Lam","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0190","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0195","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","article-title":"Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms","volume":"267","author":"Zhou","year":"2020","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0200","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/ene.14277","article-title":"Does SARS-cov-2 invade the brain? Translational lessons from animal models","volume":"27","author":"Natoli","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9378(82)90405-7","article-title":"Leiomyomatosis peritonealis disseminata: report of a case in a nonpregnant woman","volume":"144","author":"Ceccacci","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0220","first-page":"57","article-title":"The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy","volume":"2","author":"Lu","year":"2008","journal-title":"Perspect. Med. Chem."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577318","article-title":"Neuroinflammation and fibrosis in stroke: the good, the bad and the ugly","volume":"346","author":"Amruta","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0230","article-title":"Neurogenesis after stroke: a therapeutic perspective","author":"Rahman","year":"2020","journal-title":"Transl. Stroke Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.02.002_bib0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/mpat.2001.0432","article-title":"Invasion of human respiratory epithelial cells by bordetella pertussis: possible role for a filamentous hemagglutinin Arg-Gly-Asp sequence and alpha5beta1 integrin","volume":"30","author":"Ishibashi","year":"2001","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autrev.2007.03.007","article-title":"Integrins: a flexible platform for endothelial vascular tyrosine kinase receptors","volume":"7","author":"Napione","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034747","article-title":"Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling","volume":"7","author":"Clarke","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0250","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14737175.2014.964210","article-title":"Brain endothelial cell specific integrins and ischemic stroke","volume":"14","author":"Guell","year":"2014","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0271678X15616979","article-title":"Mice deficient in endothelial alpha5 integrin are profoundly resistant to experimental ischemic stroke","volume":"37","author":"Roberts","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0260","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00705-015-2579-8","article-title":"Beyond RGD: virus interactions with integrins","volume":"160","author":"Hussein","year":"2015","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1083\/jcb.127.1.257","article-title":"Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization","volume":"127","author":"Wickham","year":"1994","journal-title":"J. Cell Biol."},{"issue":"20","key":"10.1016\/j.cytogfr.2021.02.002_bib0270","doi-asserted-by":"crossref","first-page":"10839","DOI":"10.1128\/JVI.78.20.10839-10847.2004","article-title":"VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site","volume":"78","author":"Zarate","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0275","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.virol.2007.09.012","article-title":"The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells","volume":"370","author":"Xiao","year":"2008","journal-title":"Virology"},{"issue":"W1","key":"10.1016\/j.cytogfr.2021.02.002_bib0280","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"7807","key":"10.1016\/j.cytogfr.2021.02.002_bib0285","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"5742","key":"10.1016\/j.cytogfr.2021.02.002_bib0290","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0295","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.11.054","article-title":"The SARS-CoV S glycoprotein: expression and functional characterization","volume":"312","author":"Xiao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cytogfr.2021.02.002_bib0305","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00228-020-02963-4","article-title":"Inhibition of SARS-CoV-2 entry through the ACE2\/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies","volume":"76","author":"Ragia","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"27","key":"10.1016\/j.cytogfr.2021.02.002_bib0310","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2217\/fon-2020-0571","article-title":"The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer","volume":"16","author":"Mollica","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-981-15-4814-7_3","article-title":"Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Kumar","year":"2020","journal-title":"Coronavirus Disease 2019 (COVID-19)"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0320","first-page":"1","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","author":"V\u2019Kovski","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0325","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-CoV-2 infection: lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.cytogfr.2021.02.002_bib0330","first-page":"43","article-title":"Interferons","volume":"64","author":"Morris","year":"1988","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0335","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s10875-020-00824-4","article-title":"Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm","volume":"40","author":"Mahmoudi","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2020.100737","article-title":"NK cells: a double edge sword against SARS-CoV-2","volume":"77","author":"Masselli","year":"2020","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0345","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cytogfr.2020.06.008","article-title":"IL-15 immunotherapy is a viable strategy for COVID-19","volume":"54","author":"Kandikattu","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0350","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.934492","article-title":"COVID-19 and the immune system","volume":"69","author":"Paces","year":"2020","journal-title":"Physiol. Res."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0355","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"issue":"7818","key":"10.1016\/j.cytogfr.2021.02.002_bib0360","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0365","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092046","article-title":"Dendritic cells and SARS-CoV-2 infection: still an unclarified connection","volume":"9","author":"Campana","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0375","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0380","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"10235","key":"10.1016\/j.cytogfr.2021.02.002_bib0385","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0390","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0395","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41577-020-00436-4","article-title":"Not just antibodies: B cells and T cells mediate immunity to COVID-19","volume":"20","author":"Cox","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6521","key":"10.1016\/j.cytogfr.2021.02.002_bib0400","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.abd7728","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0405","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0410","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200160","article-title":"Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0415","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0420","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0425","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41577-020-0357-7","article-title":"GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches","volume":"20","author":"Lang","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0430","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.mayocp.2020.04.027","article-title":"Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)","volume":"95","author":"Vijayvargiya","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0435","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.mayocp.2020.08.038","article-title":"GM-CSF neutralization with lenzilumab in severe COVID-19 pneumonia: a case-cohort study","volume":"95","author":"Temesgen","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytox.2020.100029","article-title":"SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the\u2019 culprit lesion\u2019 of ARDS onset? What is there besides tocilizumab? SGP130Fc","volume":"2","author":"Magro","year":"2020","journal-title":"Cytokine X"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0445","article-title":"Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: an observational cohort study","volume":"24","author":"Mastroianni","year":"2020","journal-title":"E Clin. Med."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0450","article-title":"IL-10 served as an indicator in severe COVID-19 patients","author":"Huang","year":"2020","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0455","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1002\/cti2.1204","article-title":"Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19","volume":"9","author":"Neumann","year":"2020","journal-title":"Clin. Transl. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0460","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10223","key":"10.1016\/j.cytogfr.2021.02.002_bib0465","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0470","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2019.05.003","article-title":"Synergy of interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases","volume":"47","author":"Kandikattu","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0480","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0485","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420954960","article-title":"Severe acute respiratory syndrome coronavirus 2 impact on the Central nervous system: are astrocytes and microglia Main players or merely bystanders?","volume":"12","author":"Murta","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0490","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.physbeh.2017.03.035","article-title":"Hypoxia induced cognitive impairment modulating activity of Cyperus rotundus","volume":"175","author":"Kandikattu","year":"2017","journal-title":"Physiol. Behav."},{"issue":"10247","key":"10.1016\/j.cytogfr.2021.02.002_bib0495","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series","volume":"396","author":"Bradley","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0500","first-page":"343","article-title":"AhR and IDO1 in pathogenesis of covid-19 and the \u201csystemic AhR activation syndrome:\u201d a translational review and therapeutic perspectives","volume":"38","author":"Turski","year":"2020","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0505","article-title":"Long-term respiratory and neurological sequelae of COVID-19","volume":"26","author":"Wang","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0510","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"23","key":"10.1016\/j.cytogfr.2021.02.002_bib0515","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0520","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00415-020-09974-2","article-title":"Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis","volume":"267","author":"Wang","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0525","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00498","article-title":"The neurologic manifestations of coronavirus disease 2019 pandemic: a systemic review","volume":"11","author":"Tsai","year":"2020","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0530","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0535","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000509581","article-title":"Mechanisms of stroke in COVID-19","volume":"49","author":"Spence","year":"2020","journal-title":"Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.02.002_bib0540","first-page":"318","article-title":"Stroke as a complication and prognostic factor of COVID-19","volume":"35","author":"Trejo-Gabriel-Galan","year":"2020","journal-title":"Neurologia"},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0545","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jmv.25781","article-title":"The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China","volume":"92","author":"Ding","year":"2020","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000453066","article-title":"Coronavirus infections in the Central nervous system and respiratory tract Show distinct features in hospitalized children","volume":"59","author":"Li","year":"2016","journal-title":"Intervirology"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0555","article-title":"Frequent convulsive seizures in an adult patient with COVID-19: a case report","volume":"22","author":"Karimi","year":"2020","journal-title":"Iran Red Crescent Me"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0560","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.02.002_bib0565","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported olfactory and Taste disorders in patients with severe acute respiratory coronavirus 2 infection: a Cross-sectional study","volume":"71","author":"Giacomelli","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0570","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jagp.2020.04.010","article-title":"Anticipating and mitigating the impact of the COVID-19 pandemic on alzheimer\u2019s disease and related dementias","volume":"28","author":"Brown","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0575","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","article-title":"APOE e4 genotype predicts severe COVID-19 in the UK biobank Community cohort","volume":"75","author":"Kuo","year":"2020","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0580","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/mds.28261","article-title":"Impact of coronavirus disease 2019 pandemic on parkinson\u2019s disease: a Cross-sectional survey of 568 Spanish patients","volume":"35","author":"Santos-Garc\u00eda","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0585","article-title":"Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: a systematic review","author":"Kubota","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0590","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/mds.28325","article-title":"Coronavirus disease 2019 case fatality and parkinson\u2019s disease","volume":"35","author":"Zhang","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0595","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2020.08.012","article-title":"Predictors of COVID-19 outcome in parkinson\u2019s disease","volume":"78","author":"Fasano","year":"2020","journal-title":"Parkinson. Relat. Disord."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0600","unstructured":"L. Vignatelli, C. Zenesini, L.M.B. Belotti, E. Baldin, G. Bonavina, G. Calandra-Buonaura, P. Cortelli, C. Descovich, G. Fabbri, G. Giannini, M. Guarino, R. Pantieri, G. Samoggia, C. Scaglione, S. Trombetti, R. D\u2019Alessandro, F. Nonino, P.B. group, Risk of Hospitalization and Death for COVID-19 in People With Parkinson\u2019s Disease or Parkinsonism, Movement Disorders n\/a(n\/a)."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0605","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28104","article-title":"Outcome of parkinson\u2019s disease patients affected by COVID-19","volume":"35","author":"Antonini","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0610","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.parkreldis.2020.05.008","article-title":"Rapid worsening in parkinson\u2019s disease may hide COVID-19 infection","volume":"75","author":"Hainque","year":"2020","journal-title":"Parkinson. Relat. Disord."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0615","article-title":"Subacute onset dystonia in a woman affected by parkinson\u2019s disease following SARS-COV-2 infection","volume":"4","author":"Lo Monaco","year":"2021","journal-title":"Clin. Park Relat. Disord."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0620","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/mds.28170","article-title":"Effects of COVID-19 on parkinson\u2019s disease clinical features: a Community-based case-control study","volume":"35","author":"Cilia","year":"2020","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0625","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3233\/JPD-202251","article-title":"The impact of the COVID-19 pandemic on psychological distress, physical activity, and symptom severity in parkinson\u2019s disease","volume":"10","author":"van der Heide","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0630","article-title":"Influence of the COVID-19 pandemic on quality of life of patients with parkinson\u2019s disease","volume":"2020","author":"Guo","year":"2020","journal-title":"Parkinson\u2019s Disease"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0635","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/mdc3.13026","article-title":"Physical activity changes and correlate effects in patients with parkinson\u2019s disease during COVID-19 lockdown","volume":"7","author":"Schirinzi","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0640","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.581144","article-title":"COVID-19 pandemic and psychiatric symptoms: the impact on parkinson\u2019s disease in the elderly","volume":"11","author":"Janiri","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0645","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1474-4422(20)30305-7","article-title":"A case of probable parkinson\u2019s disease after SARS-CoV-2 infection","volume":"19","author":"Cohen","year":"2020","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0650","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ageing\/afu022","article-title":"Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis","volume":"43","author":"Ahmed","year":"2014","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0655","first-page":"e7352","article-title":"Neurological complications of coronavirus disease (COVID-19): encephalopathy","volume":"12","author":"Filatov","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0660","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19\u2013associated acute hemorrhagic necrotizing encephalopathy: imaging features","volume":"296","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0665","article-title":"Central nervous system complications in COVID-19 patients; A systematic review and meta-analysis based on current evidence","volume":"8","author":"MadaniNeishaboori","year":"2020","journal-title":"Arch. Acad. Emerg. Med."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0670","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/acn3.51210","article-title":"Frequent neurologic manifestations and encephalopathy-associated morbidity in covid-19 patients","volume":"7","author":"Liotta","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0675","article-title":"Neurological complications of SARS-CoV-2 infection in children: a systematic review and meta-analysis","author":"Panda","year":"2020","journal-title":"J. Trop. Pediatr."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0680","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.582794","article-title":"Electroencephalographic abnormalites in SARS-CoV-2 patients","volume":"11","author":"Besnard","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0685","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.seizure.2020.10.014","article-title":"Systematic review of EEG findings in 617 patients diagnosed with COVID-19","volume":"83","author":"Antony","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0690","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/j.wneu.2020.05.192","article-title":"Coronavirus 2019 (COVID-19)\u2013Associated encephalopathies and cerebrovascular disease: the New Orleans experience","volume":"141","author":"Scullen","year":"2020","journal-title":"World Neurosurg."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0695","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s10072-020-04592-2","article-title":"The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness","volume":"41","author":"De Lucia","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0700","first-page":"1","article-title":"Amyotrophic lateral sclerosis patients\u2019 and caregivers\u2019 distress and loneliness during COVID-19 lockdown","author":"Consonni","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0705","first-page":"1","article-title":"Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience","author":"Vasta","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0710","first-page":"1","article-title":"Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail","author":"Bombaci","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0715","article-title":"Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID-19 pandemic","author":"De Marchi","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0720","first-page":"1","article-title":"Predictors of self-perceived health worsening over COVID-19 emergency in ALS","author":"Cabona","year":"2021","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0725","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s00415-020-09879-0","article-title":"Onset of covid-19 with impaired consciousness and ataxia: a case report","volume":"267","author":"Balestrino","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0730","article-title":"Opsoclonus myoclonus ataxia syndrome (OMAS) in the setting of COVID-19 infection","author":"Shah","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0735","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mdc3.13088","article-title":"Reversible myoclonus-ataxia as a postinfectious manifestation of COVID-19","volume":"7","author":"Schellekens","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0740","article-title":"Acute cerebellar ataxia in COVID-19 infection: a case report","author":"Povlow","year":"2020","journal-title":"J. Emerg. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0745","first-page":"113","article-title":"Neurological manifestations in severe acute respiratory syndrome","volume":"14","author":"Tsai","year":"2005","journal-title":"Acta. Neurol. Taiwan"},{"issue":"26","key":"10.1016\/j.cytogfr.2021.02.002_bib0750","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-barre syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"New Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.02.002_bib0755","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","author":"Gutierrez-Ortiz","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0760","article-title":"Otolaryngological symptoms in COVID-19","author":"Elibol","year":"2020","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0765","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237146","article-title":"Peripheral facial paralysis as presenting symptom of COVID-19 in a pregnant woman","volume":"13","author":"Figueiredo","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0770","article-title":"Noteworthy neurological manifestations associated with COVID-19 infection","volume":"12","author":"Elkhouly","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0775","article-title":"Coronavirus disease 2019 complicated with bell\u2019s palsy: a case report","author":"Yue","year":"2020","journal-title":"Research Square"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0780","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.927956","article-title":"A 44-year-Old Hispanic Man with loss of Taste and bilateral facial weakness diagnosed with guillain-barr\u00e9 syndrome and bell\u2019s palsy associated with SARS-CoV-2 infection treated with intravenous immunoglobulin","volume":"21","author":"Khaja","year":"2020","journal-title":"Am. J. Case Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0785","article-title":"Brain tumors and COVID-19: the patient and caregiver experience","volume":"2","author":"Voisin","year":"2020","journal-title":"Neurooncol. Adv."},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0790","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040898","article-title":"Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT study)","volume":"10","author":"Price","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0795","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-020-03523-7","article-title":"Neurosurgical management of brain and spine tumors in the COVID-19 era: an institutional experience from the epicenter of the pandemic","volume":"148","author":"Kessler","year":"2020","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0800","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1093\/neuros\/nyaa116","article-title":"Letter: the coronavirus disease 2019 global pandemic: a neurosurgical treatment algorithm","volume":"87","author":"Burke","year":"2020","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.02.002_bib0805","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000510271","article-title":"Gamma knife radiosurgery for treatment of brain metastases during the COVID-19 outbreak","volume":"98","author":"Cris\u00e0","year":"2020","journal-title":"Stereotact. Funct. Neurosurg."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0810","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10147-020-01734-6","article-title":"Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic","volume":"25","author":"Aznab","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0815","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2020.9.FOCUS20704","article-title":"Treatment of patients with glioma during the COVID-19 pandemic: what we learned and what we take home for the future","volume":"49","author":"Pessina","year":"2020","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0820","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12890-020-01310-8","article-title":"Silent hypoxia: higher NO in red blood cells of COVID-19 patients","volume":"20","author":"Mortaz","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0825","first-page":"4","article-title":"Hypoxia: its causes and symptoms","volume":"7","author":"Cafaro","year":"1960","journal-title":"J. Am. Dent. Soc. Anesthesiol."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0830","article-title":"Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology","author":"Ribeiro","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0835","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0020764020915212","article-title":"The outbreak of COVID-19 coronavirus and its impact on global mental health","volume":"66","author":"Torales","year":"2020","journal-title":"Int. J. Soc. Psychiatry"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0840","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","article-title":"Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors","volume":"89","author":"Mazza","year":"2020","journal-title":"Brain Behav. Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0845","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA (nov, 10.1016\/S2215-0366(20)30462-4, 2020)","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0850","first-page":"1","article-title":"The mental health of healthcare workers in the COVID-19 pandemic: a systematic review","author":"Vizheh","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0855","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.05.026","article-title":"Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"88","author":"Pappa","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.02.002_bib0860","doi-asserted-by":"crossref","DOI":"10.2196\/22835","article-title":"Depression, anxiety, and lifestyle among essential workers: a web survey from Brazil and Spain during the COVID-19 pandemic","volume":"22","author":"De Boni","year":"2020","journal-title":"J. Med. Internet Res."},{"issue":"32","key":"10.1016\/j.cytogfr.2021.02.002_bib0865","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24-30, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"Mmwr-Morbid Mortal W"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.02.002_bib0870","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00949-5","article-title":"Psychiatric face of COVID-19","volume":"10","author":"Steardo","year":"2020","journal-title":"Transl. Psychiat."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0875","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2009.11.015","article-title":"Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies","volume":"37","author":"Loftis","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.02.002_bib0880","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0885","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2015.05.053","article-title":"Pathogenesis of depression: insights from human and rodent studies","volume":"321","author":"Menard","year":"2016","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.02.002_bib0890","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrn.2016.69","article-title":"Integrating neuroimmune systems in the neurobiology of depression","volume":"17","author":"Wohleb","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.02.002_bib0895","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"Kohler","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"40","key":"10.1016\/j.cytogfr.2021.02.002_bib0900","first-page":"18","article-title":"Return to nursing: a welcome approach","volume":"4","author":"Naish","year":"1990","journal-title":"Nurs. Stand"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0905","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08870440701447649","article-title":"Social support and psychological adjustment to SARS: the mediating role of self-care self-efficacy","volume":"24","author":"Mak","year":"2009","journal-title":"Psychol. Health"},{"issue":"22","key":"10.1016\/j.cytogfr.2021.02.002_bib0910","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","article-title":"Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors Long-term follow-up","volume":"169","author":"Lam","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0915","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/070674370404900607","article-title":"Stress and psychological impact on SARS patients during the outbreak","volume":"49","author":"Chua","year":"2004","journal-title":"Can. J. Psychiat."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.02.002_bib0920","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carfi","year":"2020","journal-title":"JAMA"},{"issue":"7825","key":"10.1016\/j.cytogfr.2021.02.002_bib0925","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/d41586-020-02598-6","article-title":"The lasting misery of coronavirus long-haulers","volume":"585","author":"Marshall","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0930","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-11-37","article-title":"Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; A case-controlled study","volume":"11","author":"Moldofsky","year":"2011","journal-title":"Bmc Neurol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.02.002_bib0935","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","article-title":"Treatment options for COVID-19: the reality and challenges","volume":"53","author":"Jean","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0940","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12575-020-00129-1","article-title":"Potential drugs and remedies for the treatment of COVID-19: a critical review","volume":"22","author":"Barati","year":"2020","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.01.013","article-title":"Prophylaxis for COVID-19: a systematic review","author":"Smit","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.02.002_bib0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.02.002_bib0955","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.cytogfr.2021.02.002_bib0960","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/anie.201707948","article-title":"An alphav-RGD integrin inhibitor toolbox: drug Discovery insight, challenges and opportunities","volume":"57","author":"Hatley","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.02.002_bib0965","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/1078-0432.CCR-07-4530","article-title":"Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth","volume":"14","author":"Donate","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.02.002_bib0970","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.bjc.6603171","article-title":"Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours","volume":"94","author":"Cianfrocca","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0975","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vetmic.2019.04.029","article-title":"ATN-161 reduces virus proliferation in PHEV-infected mice by inhibiting the integrin alpha5beta1-FAK signaling pathway","volume":"233","author":"Lv","year":"2019","journal-title":"Vet. Microbiol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.02.002_bib0980","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/1535-7163.MCT-06-0100","article-title":"A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo","volume":"5","author":"Khalili","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cytogfr.2021.02.002_bib0985","article-title":"The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection","author":"Beddingfield","year":"2020","journal-title":"JACC Basic Transl. Sci."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:59:58Z","timestamp":1777611598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610121000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":197,"alternative-id":["S1359610121000186"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.02.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}